Monday's session: most active stocks
By Mill Chart
Last update: Apr 29, 2024
These stocks are making the most noise in today's session. Stay tuned for the latest updates!
Top most active stocks
| Ticker | Change | Comment |
|---|---|---|
| TSLA | 15.68% | The trading session for TESLA INC (NASDAQ:TSLA) has been active, with a total volume of 187.66M shares traded so far today. NASDAQ:TSLA is advancing 15.68% today. |
| SINT | 32.43% | The trading volume for SINTX TECHNOLOGIES INC (NASDAQ:SINT) has been quite high, with 147.57M shares exchanged. The latest market activity led to a price increase of 32.43%, signaling a positive trend in the market. |
| CAUD | 79.49% | 146.29M shares of COLLECTIVE AUDIENCE INC (NASDAQ:CAUD) have been traded so far today. The latest market activity led to a price increase of 79.49%, signaling a positive trend in the market. |
| SOFI | -10.29% | So far, a total of 121.37M shares of SOFI TECHNOLOGIES INC (NASDAQ:SOFI) have been traded in today's session. NASDAQ:SOFI is declining 10.29% today. SOFI TECHNOLOGIES INC released earnings Yesterday. A press release (SoFi Technologies Reports Q1 2024 Net Revenue of $645 Million and Net Income of $88 Million, Marking Second Consecutive Quarter of GAAP Profitability) was released earlier today. |
| NKLA | 3.48% | Today, the market has shown strong interest in NIKOLA CORP (NASDAQ:NKLA) as 71.17M shares have already been traded. Leading to a price increase of 3.48%. |
| DNA | 17.18% | The trading session for GINKGO BIOWORKS HOLDINGS INC (NYSE:DNA) has been active, with a total volume of 62.99M shares traded so far today. The share price increased by 17.18%. |
| FFIE | -7.66% | The trading volume for FARADAY FUTURE INTELLIGENT E (NASDAQ:FFIE) has been quite high, with 60.81M shares exchanged. NASDAQ:FFIE is declining 7.66% today. |
| JAGX | 13.94% | The trading volume for JAGUAR HEALTH INC (NASDAQ:JAGX) has been quite high, with 59.66M shares exchanged. The market is experiencing a notable price surge, with a rise of 13.94% across the board. |
| IBRX | 25.78% | IMMUNITYBIO INC's (NASDAQ:IBRX) traded a high volume of 55.71M shares. The share price increased by 25.78% today, indicating positive momentum in the market. |
| PEGY | 4.47% | Today, there has been significant activity in the market for PINEAPPLE ENERGY INC (NASDAQ:PEGY), with a total trading volume of 48.78M shares. The share price increased by 4.47% today, indicating positive momentum in the market. |
To see the full list of most active stocks you can use our most active stocks screener.
IMMUNITYBIO INC
NASDAQ:IBRX (5/31/2024, 7:00:02 PM)
After market: 6.45 +0.03 (+0.47%)6.42
-0.19 (-2.87%)
IBRX News
16 days ago - ImmunityBio, Inc.Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast
23 days ago - InvestorPlaceIBRX Stock Earnings: ImmunityBio Misses EPS, Beats Revenue for Q1 2024IBRX stock results show that ImmunityBio missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
24 days ago - InvestorPlaceThe 3 Best Bargain Stocks to Buy in May 2024There are several types of bargain stocks for investors to consider. Here are the three best bargain stocks to buy now.
26 days ago - ImmunityBio, Inc.ImmunityBio Completes GMP Drug Substance Manufacturing Sufficient for 170,000 Doses of ANKTIVA®
a month ago - InvestorPlaceEven Worse than Gamestop? 3 Meme Stocks That Are Screaming SellsHere are just a few of the top meme stocks to sell immediately. In fact, I wouldn't waste investment dollars on any.
a month ago - ImmunityBio, Inc.ImmunityBio, Serum Institute of India Agree on an Exclusive Arrangement for Global Supply of Bacillus Calmette-Guerin (BCG) Across All Cancer Types
a month ago - USA News GroupBiotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050/PRNewswire/ -- USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed...
a month ago - USA News GroupBiotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050/CNW/ -- USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of...
a month ago - ImmunityBio, Inc.ImmunityBio Executive Chairman Dr. Patrick Soon-Shiong to Discuss ANKTIVA® Approval in Fireside Chat at the Annual Conference of the American Urological Association
a month ago - InvezzWhat’s going on with the ImmunityBio (IBRX) stock price?ImmunityBio (NASDAQ: IBRX) stock price has gone parabolic as investors cheer the recent approval of Anktiva, its cancer drug. It has risen for two straight days and is now sitting at its highest level since September 2021. It is up by over 770% from its lowest point in 2023, giving it a market cap of […]
